BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 16034938)

  • 1. Combination injectable contraceptives for contraception.
    Gallo MF; Grimes DA; Schulz KF; d'Arcangues C; Lopez LM
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004568. PubMed ID: 16034938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination injectable contraceptives for contraception.
    Gallo MF; Grimes DA; Lopez LM; Schulz KF; d'Arcangues C
    Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD004568. PubMed ID: 18843662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination injectable contraceptives for contraception.
    Gallo MF; Grimes DA; Lopez LM; Schulz KF; d'Arcangues C
    Cochrane Database Syst Rev; 2013; 3():CD004568. PubMed ID: 23641480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depot medroxyprogesterone versus norethisterone oenanthate for long-acting progestogenic contraception.
    Draper BH; Morroni C; Hoffman M; Smit J; Beksinska M; Hapgood J; Van der Merwe L
    Cochrane Database Syst Rev; 2006 Jul; (3):CD005214. PubMed ID: 16856087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-acting hormonal contraceptives for women.
    Garza-Flores J; Hall PE; Perez-Palacios G
    J Steroid Biochem Mol Biol; 1991; 40(4-6):697-704. PubMed ID: 1958567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal bleeding disturbances associated with the discontinuation of long-acting injectable contraceptives. From the World Health Organization Special Programme for Research, Development, and Research Training in Human Reproduction; Task Force on Long-acting Systemic Agents for the Regulation of Fertility.
    Gray RH; Parker RA; Diethelm P
    Br J Obstet Gynaecol; 1981 Mar; 88(3):317-21. PubMed ID: 7008825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
    Swenson I; Khan AR; Jahan FA
    Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-a-month injectable contraceptives: efficacy and reasons for discontinuation.
    Koetsawang S
    Contraception; 1994 Apr; 49(4):387-98. PubMed ID: 8013221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic effects of once-a-month combined injectable contraceptives.
    Sang GW
    Contraception; 1994 Apr; 49(4):361-85. PubMed ID: 8013220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report.
    Contraception; 1983 Jul; 28(1):1-20. PubMed ID: 6226488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-a-month estrogen/progestogen injectables.
    D'arcangues C
    Entre Nous Cph Den; 1991 Dec; (19):15. PubMed ID: 12222332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies to improve adherence and continuation of shorter-term hormonal methods of contraception.
    Mack N; Crawford TJ; Guise JM; Chen M; Grey TW; Feldblum PJ; Stockton LL; Gallo MF
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD004317. PubMed ID: 31013349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal bleeding patterns in women using once-a-month injectable contraceptives.
    Fraser IS
    Contraception; 1994 Apr; 49(4):399-420. PubMed ID: 8013222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facts about once-a-month injectable contraceptives: memorandum from a WHO meeting.
    Bull World Health Organ; 1993; 71(6):677-89. PubMed ID: 8313486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
    Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies to improve adherence and acceptability of hormonal methods of contraception.
    Halpern V; Lopez LM; Grimes DA; Stockton LL; Gallo MF
    Cochrane Database Syst Rev; 2013 Oct; (10):CD004317. PubMed ID: 24163097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey of different approaches to management of menstrual disturbances in women using injectable contraceptives.
    Fraser IS
    Contraception; 1983 Oct; 28(4):385-97. PubMed ID: 6230212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient acceptability and satisfaction with Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension).
    Shulman LP; Oleen-Burkey M; Willke RJ
    Contraception; 1999 Oct; 60(4):215-22. PubMed ID: 10640168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of ovulation return upon discontinuation of once-a-month injectable contraceptives.
    Bassol S; Garza-Flores J
    Contraception; 1994 May; 49(5):441-53. PubMed ID: 8045131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability study of the two versus three monthly injectable contraceptives.
    Aly FA; El-genedi MM; Toppozada HK; El-abd M; Loutfi I
    Dirasat Sukkaniyah; 1984; 11(69):27-39. PubMed ID: 12179796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.